Cued movement preparation and movement coding in human thalamic neurons
Objective: To study motor cognition in the human motor thalamus at the single cell and population level. Background: The motor thalamus, in particular its cerebellar-receiving…Double lesion magnetic resonance-guided focused ultrasound treatment for cervical dystonia: a pilot study of two targets combination based on clinical symptoms
Objective: to investigate the safety and efficacy of double lesion MRgFUS intervention for treating cervical drug-refractory dystonia based on clinical signs due to the hypothesis…How COVID-19 Impacted Patients with Wilson’s disease? A Questionnaire-based Study From An Indian Movement Disorder Clinic
Objective: To assess the impact of COVID-19 related disruption on patients with Wilson’s disease. Background: Health-care systems around the world were drastically impacted by the…Assessing akinesia domains during multitasking in Parkinson’s disease
Objective: To explore performance differences in single- versus dual-tasking conditions between healthy controls (HC) and Parkinson's disease (PD) patients. Background: Akinesia, comprising slowness (bradykinesia), reduction…Case of neuroferritinopathy with isolated dystonic leg cramps and normal neuroimaging
Objective: To describe a case of genetically proven neuroferritinopathy with isolated dystonic leg cramps and normal neuro-imaging. Background: Neuroferritinopathy(NF) is an autosomal dominant condition characterized…Alopecia in females with young onset Parkinson’s Disease: an exploratory survey
Objective: To explore the symptoms of females with young onset Parkinson's Disease (YOPD), specifically alopecia, in comparison to females with traditional onset Parkinson’s Disease (TOPD).…Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation.
Objective: To characterize reported infusion site infection adverse events (AEs) and their clinical management in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDP/CDP). Background:…Motor phenotype and disease burden among Parkinson’s disease patients of Addis Ababa, Ethiopia.
Objective: This study aims to characterize the motor phenotype of Parkinson’s disease (PD), compare disease severity and to determine quality of life among the different…Manifestations of aging and Parkinson’s Disease in low-frequency fluctuations of postural sway velocity
Objective: To distinguish the effects of aging and Parkinson's disease on balance control. Background: Many balance control measures are derived from spontaneous fluctuations of the center…Increased MD and decreased FA reflect cognitive impairment in PSP
Objective: To identify white matter (WM) alterations associated with cognitive impairment in progressive supranuclear palsy (PSP). Background: PSP is accompanied with cognitive impairment [1;2], but…
- « Previous Page
- 1
- …
- 589
- 590
- 591
- 592
- 593
- …
- 1942
- Next Page »